Publications de l'équipe TOnG

> 2018

The expression of EMX2 lead to cell cycle arrest in glioblastoma cell line.
Monnier A, Boniface R, Bouvet R, Etcheverry A, Aubry M, Avril T, Quillien V, Chevet E, Mosser J.
BMC Cancer 2018 Dec.

Integration of transcriptome and proteome profiles in glioblastoma: looking for the missing link.
Lemée JM, Clavreul A, Aubry M, Com E, de Tayrac M, Mosser J, Menei P.
BMC Mol Biol. 2018 Nov.

Predictive biomarkers of response to immune checkpoint inhibitors.
Frelau A, Pracht M, Le Sourd S, Lespagnol A, Corre R, Ménard C, Tarte K, Mosser J, Edeline J.
Bull Cancer. 2018 Mar.

A novel prognostic six-CpG signature in glioblastomas.
Yin AA, Lu N, Etcheverry A, Aubry M, Barnholtz-Sloan J, Zhang LH, Mosser J, Zhang W, Zhang X, Liu YH, He YL.
CNS Neurosci Ther. 2018 Mar.

Mutational Landscape of DDR2 Gene in Lung Squamous Cell Carcinoma Using Next-generation Sequencing.
Ricordel C, Lespagnol A, Llamas-Gutierrez F, de Tayrac M, Kerjouan M, Fievet A, Hamdi-Rozé H, Aliouat A, Desrues B, Mosser J, Léna H.
Clin Lung Cancer. 2018 Mar.

> 2017

CD90 Expression Controls Migration and Predicts Dasatinib Response in Glioblastoma.
Avril T, Etcheverry A, Pineau R, Obacz J, Jegou G, Jouan F, Le Reste PJ, Hatami M, Colen RR, Carlson BL, Decker PA, Sarkaria JN, Vauléon E, Chiforeanu DC, Clavreul A, Mosser J, Chevet E, Quillien V.
Clin Cancer Res. 2017 Dec.

Clinical and molecular characteristics of non-small-cell lung cancer (NSCLC) harboring EGFR mutation: results of the nationwide French Cooperative Thoracic Intergroup (IFCT) program.
Leduc C, Merlio JP, Besse B, Blons H, Debieuvre D, Bringuier PP, Monnet I, Rouquette I, Fraboulet-Moreau S, Lemoine A, Pouessel D, Mosser J, Vaylet F, Langlais A, Missy P, Morin F, Moro-Sibilot D, Cadranel J, Barlesi F, Beau-Faller M; French Cooperative Thoracic Intergroup (IFCT).
Ann Oncol. 2017 Nov.

Hilar fat infiltration: A new prognostic factor in metastatic clear cell renal cell carcinoma with first-line sunitinib treatment.
Kammerer-Jacquet SF, Brunot A, Bensalah K, Campillo-Gimenez B, Lefort M, Bayat S, Ravaud A, Dupuis F, Yacoub M, Verhoest G, Peyronnet B, Mathieu R, Lespagnol A, Mosser J, Edeline J, Laguerre B, Bernhard JC, Rioux-Leclercq N.
Urol Oncol. 2017 Oct.

Correlation of c-MET Expression with PD-L1 Expression in Metastatic Clear Cell Renal Cell Carcinoma Treated by Sunitinib First-Line Therapy.
Kammerer-Jacquet SF, Medane S, Bensalah K, Bernhard JC, Yacoub M, Dupuis F, Ravaud A, Verhoest G, Mathieu R, Peyronnet B, Brunot A, Laguerre B, Lespagnol A, Mosser J, Dugay F, Belaud-Rotureau MA, Rioux-Leclercq N.
Target Oncol. 2017 Aug.

Integrative analysis of novel hypomethylation and gene expression signatures in glioblastomas.
Yin A, Etcheverry A, He Y, Aubry M, Barnholtz-Sloan J, Zhang L, Mao X, Chen W, Liu B, Zhang W, Mosser J, Zhang X.
Oncotarget. 2017 Jul.

Synchronous Metastatic Clear-Cell Renal Cell Carcinoma: A Distinct Morphologic, Immunohistochemical, and Molecular Phenotype.
Kammerer-Jacquet SF, Brunot A, Pladys A, Bouzille G, Dagher J, Medane S, Peyronnet B, Mathieu R, Verhoest G, Bensalah K, Edeline J, Laguerre B, Lespagnol A, Mosser J, Dugay F, Belaud-Rotureau MA, Rioux-Leclercq N.
Clin Genitourin Cancer. 2017 Feb.

Independent association of PD-L1 expression with noninactivated VHL clear cell renal cell carcinoma-A finding with therapeutic potential.
Kammerer-Jacquet SF, Crouzet L, Brunot A, Dagher J, Pladys A, Edeline J, Laguerre B, Peyronnet B, Mathieu R, Verhoest G, Patard JJ, Lespagnol A, Mosser J, Denis M, Messai Y, Gad-Lapiteau S, Chouaib S, Belaud-Rotureau MA, Bensalah K, Rioux-Leclercq N.
Int J Cancer. 2017 Jan.

> 2016

Synchronous Metastatic Clear-Cell Renal Cell Carcinoma: A Distinct Morphologic, Immunohistochemical, and Molecular Phenotype.
Kammerer-Jacquet SF, Brunot A, Pladys A, Bouzille G, Dagher J, Medane S, Peyronnet B, Mathieu R, Verhoest G, Bensalah K, Edeline J, Laguerre B, Lespagnol A, Mosser J, Dugay F, Belaud-Rotureau MA, Rioux-Leclercq N.
Clin Genitourin Cancer. 2016 Jun.

Routine molecular profiling of cancer: results of a one-year nationwide program of the French Cooperative Thoracic Intergroup (IFCT) for advanced non-small cell lung cancer (NSCLC) patients.
Barlesi F, Mazieres J, Merlio JP, Debieuvre D, Mosser J, Lena H, Ouafik L, Besse B, Rouquette I, Westeel V, Escande F, Monnet I, Lemoine A, Veillon R, Blons H, Audigier-Valette C, Bringuier PP, Lamy R, Beau-Faller M, Pujol JL, Sabourin JC, Penault-Llorca F, Denis MG, Lantuejoul S, Morin F, Tran Q, Missy P, Langlais A, Milleron B, Cadranel J, Soria JC, Zalcman G.
Lancet. 2016 April.

> 2015

From the Core to beyond the Margin: a genomic picture of glioblastoma intratumor heterogeneity. 
Aubry M*, de Tayrac M*, Etcheverry A, Clavreul A, Menei P, Mosser J.
OncoTarget. 2015 May.

GNPAT variant associated with severe iron overload in HFE hemochromatosis.
Bardou-Jacquet E, de Tayrac M, Mosser J, Deugnier Y.
Hepatology. 2015 Apr.

Characterizing the peritumoral brain zone in glioblastoma: a multidisciplinary analysis.
Lemée JM, Clavreul A, Aubry M, Com E, de Tayrac M, Eliat PA, Henry C, Rousseau A, Mosser J, Menei P.
J Neurooncol. 2015 Mar.

Homozygous STIL Mutation Causes Holoprosencephaly and Microcephaly in Two Siblings.
Mouden C, de Tayrac M, Dubourg C, Rose S, Carre W, Hamdi-Rozé H, Babron Mc, Akloul L, Héron-Longe B, Odent S, Dupé V, Giet R, David V.
PLoS One. 2015 Feb.

> 2014

Identification of two glioblastoma-associated stromal cell subtypes with different carcinogenic properties in histologically normal surgical margins.
Clavreul A, Etcheverry A, Tétaud C, Rousseau A, Avril T, Henry C, Mosser J, Menei P.
J Neurooncol. 2014 Dec / 2015 Mar.

EFGR-mutant lung adenocarcinoma and Li-Fraumeni syndrome: Report of two cases and review of the literature.
Ricordel C, Labalette-Tiercin M, Lespagnol A, Kerjouan M, Dugast C, Mosser J, Desrues B, Léna H.
Lung Cancer. 2014 Nov / 2015 Jan.

Genome-wide association study identifies TF as a significant modifier gene of iron metabolism in HFE hemochromatosis.
de Tayrac M, Roth MP, Jouanolle AM, Coppin H, le Gac G, Piperno A, Férec C, Pelucchi S, Scotet V, Bardou-Jacquet E, Ropert M, Bouvet R, Génin E, Mosser J, Deugnier Y.
J Hepatol. 2014 Oct / 2015 Mar.

Proteomic analysis underlines the usefulness of both primary adherent and stem-like cell lines for studying proteins involved in human glioblastoma.
Collet B, Avril T, Aubry M, Hamlat A, Le Reste PJ, Chiforeanu D, Vauleon E, Mosser J, Quillien V.
Journal Proteomics. 2014 Oct.

DGKI Methylation Status Modulates the Prognostic Value of MGMT in Glioblastoma Patients Treated with Combined Radio-Chemotherapy with Temozolomide.
Etcheverry A*, Aubry M*, Idbaih A, Vauleon E, Marie Y, Menei P, Boniface R, Figarella-Branger D, Karayan-Tapon L, Quillien V, Sanson M, de Tayrac M, Delattre JY, Mosser J.
PloS One. 2014 Sep.

Gene expression profile in hereditary transthyretin amyloidosis: differences in targeted and source organs.
Norgren N, Olsson M, Nyström H, Ericzon BG, de Tayrac M, Genin E, Planté-Bordeneuve V, Suhr OB.
Amyloid. 2014 Jun.

ImmunoFISH is a reliable technique for the assessment of 1p and 19q status in oligodendrogliomas.
Duval C, de Tayrac M, Sanschagrin F, Michaud K, Gould PV, Saikali S.
PLoS One. 2014 Jun.

Glioblastoma-associated stromal cells (GASCs) from histologically normal surgical margins have a myofibroblast phenotype and angiogenic properties.
Clavreul A, Guette C, Faguer R, Tétaud C, Boissard A, Lemaire L, Rousseau A, Avril T, Henry C, Coqueret O, Menei P.
J Pathol. 2014 May.

Outcome-based determination of optimal pyrosequencing assay for MGMT methylation detection in glioblastoma patients,
Quillien V, Lavenu A, Sanson M, Legrain M, Dubus P, Karayan-Tapon L, Mosser J, Ichimura K, Figarella-Branger D.
J Neurooncol. 2014 Feb.

A Multicenter Blinded Study Evaluating EGFR and KRAS Mutation Testing Methods in the Clinical Non–Small Cell Lung Cancer Setting—IFCT/ERMETIC2 Project Part 1: Comparison of Testing Methods in 20 French Molecular Genetic National Cancer Institute Platforms.
Beau-Faller M, Blons H, Domerg C, Gajda D, Richard N, Escande F, Solassol J, Denis MG, Cayre A, Nanni-Metellus I, Olschwang S, Lizard S, Piard F, Pretet JL, de Fraipont F, Bièche I, de Cremoux P, Rouquette I, Bringuier PP, Mosser J, Legrain M, Voegeli AC, Saulnier P, Morin F, Pignon JP, Zalcman G, Cadranel J.
J Mol Diagn. 2014 Jan.

Nomogram for Predicting Resistance to Sunitinib in Patients with Metastatic Clear Cell Renal Carcinoma.
Kammerer-Jacquet SF, Belaud-Rotureau MA, Oger E, Verhoest G, Lespagnol A, Edeline J, Jaillard S, Laguerre B, Vauleon E, Mosser J.
Laboratory Investigation. 2014.

> 2013

Tumor migration of human glioblastoma is modulated by the molecule CD90 (thy-1).
Avril T, Abderrahmane H, Le Rests JP, Mosser J, Quillien V.
Neuro Oncol. 2013 Nov.

Prognostic Significance of EDN/RB, HJURP, p60/CAF-1 and PDLI4, Four New Markers in High-Grade Gliomas.
de Tayrac M, Saikali S, Aubry M, Bellaud P, Boniface R, Quillien V, Mosser J.
PloS One. 2013 Sep.

Proteomic analysis of glioblastomas: what is the best brain control sample? 
Lemée JM, Com E, Clavreul A, Avril T, Quillien V, de Tayrac M, Pineau C, Menei P.
J Proteomics. 2013 Jun.

Flow cytometry analysis of tumor-infiltrating cells in a large series of glioblastoma patients: impact of lymphocyte infiltration on survival.
Avril T, Vauleon E, Abderhamman H, Mosser J, Quillien V.
Neuro Oncology. 2013.

> 2012

Cyclopamine cooperates with EGFR inhibition to deplete stem-like cancer cells in glioblastoma-derived spheroid cultures. 
Eimer S, Dugay F, Airiau K, Avril T, Quillien V, Belaud-Rotureau MA, Belloc F.
Neuro Oncol. 2012 Dec.

Iron excess limits HHIPL-2 gene expression and decreases osteoblastic activity in human MG-63 cells.
Doyard M, Fatih N, Monnier A, Island ML, Aubry M, Leroyer P, Bouvet R, Chalès G, Mosser J, Loréal O, Guggenbuhl P.
Osteoporos Int. 2012 Oct.

Comparative assessment of 5 methods (methylation-specific polymerase chain reaction, MethyLight, pyrosequencing, methylation-sensitive high-resolution melting, and immunohistochemistry) to analyze O6-methylguanine-DNA-methyltranferase in a series of 100 glioblastoma patients. 
Quillien V, Lavenu A, Karayan-Tapon L, Carpentier C, Labussière M, Lesimple T, Chinot O, Wager M, Honnorat J, Saikali S, Fina F, Sanson M, Figarella-Branger D.
Cancer. 2012 Sep.

Immune genes are associated with human glioblastoma pathology and patient survival.
Vauléon E, Avril T, Abderrahmane H, Etcheverry A, Chiforeanu Dan C, Menei P, Mosser J, Quillien V, Aubry M.
BMC Med Gen. 2012 Sep.

Comprehensive analysis of current approaches to inhibit regulatory T cells in cancer.
Pere H, Tanchot C, Bayry J, Terme M, Taieb J, Badoual C, Adotevi O, Merillon N, Marcheteau E, Quillien V, Banissi C, Carpentier A, Sandoval F, Nizard M, Quintin-Colonna F, Kroemer G, Fridman WH, Zitvogel L, Oudard S and Tartour E.
Oncoimmunology. 2012 May.

Human Glioblastoma Stem-Like Cells are More Sensitive to Allogeneic NK and T Cell-Mediated Killing Compared with Serum-Cultured Glioblastoma Cells
Avril T, Vauleon E, Hamlat A, Saikali S, Etcheverry A, Delmas C, Diabira S, Mosser J, Quillien V.
Brain Path. 2012 Mar.

Lesimple Retrospective analysis of 24 recurrent glioblastoma after chemoradiation and treated with nitrosoureas or irinotecan and bevacizumab. 
Vauleon E, Mesbah H, Gedouin D, Lecouillard I, Louvel G, Hamlat A, Riffaud L, Carsin B, Quillien V, Audrain O, Lesimple T.
Bull Cancer. 2012 Feb.

Isolation of a new cell population in the glioblastoma microenvironment.
Clavreul A, Etcheverry A, Chassevent A, Quillien V, Avril T, Jourdan ML, Michalak S, François P, Carré JL, Mosser J, Menei P.
J Neurooncol. 2012 Feb.

Sentinel lymph node analysis in breast cancer: contribution of one-step nucleic acid amplification (OSNA). 
Godey F, Leveque J, Tas P, Gandon G, Poree P, Mesbah H, Lavoue V, Quillien V, Athias CB.
Breast Cancer Res Treat. 2012 Jan.

> 2011

5q12. 1 deletion: delineation of a phenotype including mental retardation and ocular defects.
Jaillard S, Andrieux J, Plessis G, Krepischi AC, Lucas J, David V, Le Brun M, Bertola DR, David A, Belaud-Rotureau MA, Mosser J, Lazaro L, Treguier C, Rosenberg C, Odent S, Dubourg C.
Am J Med Genet A. 2011 Apr.

Mechanisms of immunomodulation in human glioblastoma.
Avril T, Vauleon E, Tanguy-Royer S, Mosser J, Quillien V.​
Immunotherapy. 2011 Apr.

Differential analysis of glioblastoma multiforme proteome by a 2D-DIGE approach.
Collet B, Guitton N, Saïkali S, Avril T, Pineau C, Abderrahmane H, Mosser J, Quillien V.
Proteome Sci. 2011 Apr.

Clinical and molecular characterization of 17q21. 31 microdeletion syndrome in 14 French patients with mental retardation.
Dubourg C, Sanlaville D, Doco-Fenzy M, Le Caignec C, Missirian C, Jaillard S, Schluth-Bolard C, Landais E, Boute O, Philip N, Toutain A, David A, Edery P, Moncla A, Martin-Coignard D, Vincent-Delorme C, Mortemousque I, Duban-Bedu B, Drunat S, Beri M, Mosser J, Odent S, David V, Andrieux J.
Eur J Med Genet. 2011 Mar-Apr.

[MGMT analysis in gliomas].
Quillien V, Vauléon E, Saikali S, Lesimple T, Abderrahmane H, Etcheverry A, Mosser J.
Bull Cancer. 2011 Mar.

A 4-gene signature associated with clinical outcome in high-grade gliomas.
de Tayrac M*, Aubry M*, Saïkali S, Etcheverry A, Surbled C, Guénot F, Galibert MD, Hamlat A, Lesimple T, Quillien V, Menei P, Mosser J.
Clin Cancer Res. 2011 Jan.

> 2010

Distinct effects of human glioblastoma immunoregulatory molecules programmed cell death ligand-1 (PDL-1) and indoleamine 2,3-dioxygenase (IDO) on tumour-specific T cell functions. 
Avril T, Saikali S, Vauléon E, Jary A, Hamlat A, de Tayrac M, Mosser J, Quillien V.
J Neuroimmunol. 2010 Aug.

DNA methylation in glioblastoma: impact on gene expression and clinical outcome. 
Etcheverry A, Aubry M, de Tayrac M, Vauléon E, Boniface R, Guénot F, Saikali S, Hamlat A, Menei P, Quillien V, Mosser J.
BMC Genomics. 2010 Dec.

Catégorisation des glioblastomes : typologie et profilage du génome. [Classification of glioblastoma and genome profiling]. 
de Tayrac M, Mosser J.
Neurochirurgie. 2010 Dec

In vivo identification of solar radiation-responsive gene network: role of the p38 stress-dependent kinase. 
Mouchet N, Adamski H, Bouvet R, Corre S, Courbebaisse Y, Watier E, Mosser J, Chesné C, Galibert MD.
PLoS One. 2010 May.

CD9 expression can be used to predict childhood TEL/AML1-positive acute lymphoblastic leu kemia: Proposal for an accelerated diagnostic flowchart. 
Gandemer V, Aubry M, Roussel M, Rio AG, de Tayrac M, Vallée A, Mosser J, Ly-Sunnaram B, Galibert MD.
Leuk Res. 2010 Apr.

Identification of gene copy number variations in patients with mental retardation using array-CGH: Novel syndromes in a large French series. 
Jaillard S, Drunat S, Bendavid C, Aboura A, Etcheverry A, Journel H, Delahaye A, Pasquier L, Bonneau D, Toutain A, Burglen L, Guichet A, Pipiras E, Gilbert-Dussardier B, Benzacken B, Martin-Coignard D, Henry C, David A, Lucas J, Mosser J, David V, Odent S, Verloes A, Dubourg C.
Eur J Med Genet. 2010 Mar-Apr.

Orchestrated transcription of biological processes in the marine picoeukaryote Ostreococcus exposed to light/dark cycles. 
Monnier A, Liverani S, Bouvet R, Jesson B, Smith JQ, Mosser J, Corellou F, Bouget FY.
BMC Med Gen. 2010 Mar.

A common SNP near BMP2 is associated with severity of the iron burden in HFE p.C282Y homozygous patients: A follow-up. 
Milet J, Le Gac G, Scotet V, Gourlaouen I, Thèze C, Mosser J, Bourgain C, Deugnier Y, Ferec C.
Blood Cells Mol Dis. 2010 Jan.

In vivo identification of solar radiation-responsive gene network: role of the p38 stress-dependent kinase. 
Mouchet N, Adamski H, Bouvet R, Corre S, Courbebaisse Y, Watier E, Mosser J, Chesné C, Galibert MD.
PLoS One. 2010 May.

Overview of cellular immunotherapy for patients with glioblastoma. 
Vauléon E, Avril T, Collet B, Mosser J, Quillien V.
Clin Dev Immunol. 2010.

> 2009

Array-CGH analysis indicates a high prevalence of genomic rearrangements in Holoprosencephaly: an updated map of candidate loci.
Bendavid C, Rochard L, Dubourg C, Seguin J, Gicquel I, Pasquier L, Vigneron J, Laquerrière A, Marcorelles P, Jeanne-Pasquier C, Rouleau C, Jaillard S, Mosser J, Odent S, David V.
Hum. Mutat., 2009.

Simultaneous analysis of distinct Omics data sets with integration of biological knowledge: Multiple Factor Analysis approach.
de Tayrac M, Lê S, Aubry M, Mosser J, Husson F.
BMC Genomics, 2009.

Gene expression meta-analysis identifies grading and survival markers in anaplastic glioma.
de Tayrac M, Aubry M, Saikali S, Surbled C, Boniface R, Etcheverry A, Menei P, Mosser J.
2009, 3rd Quadrennial Meeting of the World-Federation-of-Neuro-Oncoloyg/6th Meeting of the Asian-Society-for-Neuro-Oncology, Yokohama, Japan, 11(6):925 P47. Neuro-oncology.

Integrative genome-wide analysis reveals a robust genomic glioblastoma signature associated with copy number driving changes in gene expression.
de Tayrac M, Etcheverry A, Aubry M, Saïkali S, Hamlat A, Quillien V, Le Treut A, Galibert MD, Mosser J.
Genes Chromosomes Cancer, 2009.

Integration of genomic alterations and expression profiling in glioblastoma multiforme.
Mosser J, Etcheverry A, Saikali S, Aubry M, Hamlat A, Quillien V, Menei P, de Tayrac M.
2009, 3rd Quadrennial Meeting of the World-Federation-of-Neuro-Oncoloyg/6th Meeting of the Asian-Society-for-Neuro-Oncology, Yokohama, Japan, 11(6):890 O-59. Neuro-oncology.

> 2008

Iron-related transcriptomic variations in Caco-2 cells: In silico perspectives.
Aubry M, Monnier A, Chicault C, Galibert MD, Burgun A, Mosser J.
Biochimie, 2008.

Facteurs acquis et génétiques de modulation de la pénétrance de l’hémochromatose HFE [Acquired and genetic factors influencing the penetrance of HFE haemochromatosis].
Deugnier Y, Bourgain C, Mosser J.
Bull. Acad. Natl. Med., 2008.

Modifying factors of the HFE hemochromatosis phenotype.
Deugnier Y, Mosser J.
Expert Rev. Gastroenterol. Hepatol., 2008.

Iron regulates phosphorylation of Smad1/5/8 and gene expression of Bmp6, Smad7, Id1, and Atoh8 in the mouse liver.
Kautz L, Meynard D, Monnier A, Darnaud V, Bouvet R, Wang RH, Deng C, Vaulont S, Mosser J, Coppin H, Roth MP.
Blood, 2008.

> 2007

Integrating biological pathways in disease ontologies.
Chabalier J, Mosser J, Burgun A.
Medinfo, 2007.

A transversal approach to predict gene product networks from ontology-based similarity.
Chabalier J, Mosser J, Burgun A.
BMC Bioinformatics.

Gene expression profiling of Hfe-/- liver and duodenum in mouse strains with differing susceptibilities to iron loading: identification of transcriptional regulatory targets of Hfe and potential hemochromatosis modifiers.
Coppin H, Darnaud V, Kautz L, Meynard D, Aubry M, Mosser J, Martinez M, Roth MP.
Genome Biol., 2007.

Five distinct biological processes and 14 differentially expressed genes characterize TEL/AML1-positive leukemia.
Gandemer V, Rio AG, de Tayrac M, Sibut V, Mottier S, Ly Sunnaram B, Henry C, Monnier A, Berthou C, Le Gall E, Le Treut A, Schmitt C, Le Gall JY, Mosser J, Galibert MD.
BMC Genomics, 2007.

Prognostic signature of ALL blasts at diagnosis: What can we really find?.
Gandemer V, de Tayrac M, Mosser J, Galibert MD.
Leuk. Res., 2007.

A method exploiting syntactic patterns and the UMLS semantics for aligning biomedical ontologies: The case of OBO disease ontologies.
Marquet G, Mosser J, Burgun A.
Int. J. Med. Inform., 2007.

Grading glioma tumors using OWL-DL and NCI Thesaurus.
Marquet G, Dameron O, Saikali S, Mosser J, Burgun A.
AMIA Annu. Symp. Proc., 2007.

Common variants in the BMP2, BMP4, and HJV genes of the hepcidin regulation pathway modulate HFE hemochromatosis penetrance.
Milet J, Dehais V, Bourgain C, Jouanolle AM, Mosser A, Perrin M, Morcet J, Brissot P, David V, Deugnier Y, Mosser J.
Am. J. Hum. Genet., 2007.

Light-dependent regulation of cell division in Ostreococcus: Evidence for a major transcriptional input.
Moulager M, Monnier A, Jesson B, Bouvet R, Mosser J, Schwartz C, Garnier L, Corellou F, Bouget FY.
Plant Physiol., 2007.

> 2006

Differential expression of genes related to HFE and iron status in mouse duodenal epithelium.
Abgueguen E, Toutain B, Bédrine H, Chicault C, Orhant M, Aubry M, Monnier A, Mottier S, Jouan H, Bahram S, Mosser J, Fergelot P.
Mamm. Genome, 2006.

Combining evidence, biomedical literature and statistical dependence: new insights for functional annotation of gene sets.
Aubry M, Monnier A, Chicault C, de Tayrac M, Galibert MD, Burgun A, Mosser J.
BMC Bioinformatics, 2006.

Microarray analysis of differential gene expression in the liver of lean and fat chickens.
Bourneuf E, Hérault F, Chicault C, Carré W, Assaf S, Monnier A, Mottier S, Lagarrigue S, Douaire M, Mosser J, Diot C.
Gene, 2006.

Iron-related transcriptomic variations in CaCo-2 cells, an in vitro model of intestinal absorptive cells.
Chicault C, Toutain B, Monnier A, Aubry M, Fergelot P, Le Treut A, Galibert MD, Mosser J.
Physiol. Genomics, 2006.

In vivo and ex vivo UV-induced analysis of pigmentation gene expressions.
Corre S, Mekideche K, Adamski H, Mosser J, Watier E, Galibert MD.
J. Invest. Dermatol., 2006.

Aligning biomedical ontologies using lexical methods and the UMLS: the case of disease ontologies.
Marquet G, Mosser J, Burgun A.
Stud. Health Technol. Inform., 2006.

> 2005

Phenotypic expression in detected C282Y homozygous women depends on body mass index.
Lainé F, Jouannolle AM, Morcet J, Brigand A, Pouchard M, Lafraise B, Mosser J, David V, Deugnier Y.
J. Hepatol., 2005.

Le métabolisme du fer chez l’homme. [Human iron metabolism].
Le Gall JY, Jouanolle AM, Mosser J, David V.
Bull. Acad. Natl. Med., 2005.

> 2004

Transcriptome variations in human CaCo-2 cells: a model for enterocyte differentiation and its link to iron absorption.
Bédrine-Ferran H, Le Meur N, Gicquel I, Le Cunff M, Soriano N, Guisle I, Mottier S, Monnier A, Teusan R, Fergelot P, Le Gall JY, Léger J, Mosser J.
Genomics, 2004.

NOD2/CARD15 gene polymorphisms in Crohn's disease: a genotype- phenotype analysis.
Heresbach D, Gicquel-Douabin V, Birebent B, D'halluin PN, Heresbach-Le Berre N, Dreano S, Siproudhis L, Dabadie A, Gosselin M, Mosser J, Semana G, Bretagne JF, Yaouanq J.
Eur. J. Gastroenterol. Hepatol., 2004.

Génétique des surcharges martiales primitives [Genetics of hereditary iron overload].
Le Gall JY, Jouanolle AM, Fergelot P, Mosser J, David V.
Bull. Acad. Natl. Med., 2004.

> 2003

Over-expression of wild-type and mutant HFE in a human melanocytic cell line reveals an intracellular bridge between MHC class I pathway and transferrin iron uptake.
Fergelot P, Orhant M, Thénié A, Loyer P, Ropert-Bouchet M, Lohyer S, Le Gall JY, Mosser J.
Biol. Cell, 2003.

> 2002

Iron overload in mice expressing HFE exclusively in the intestinal villi provides evidence that HFE regulates a functional cross-talk between crypt and villi enterocytes.
Fergelot P, Ropert-Bouchet M, Abgueguen E, Orhant M, Radosavljevic M, Grimber G, Jouan H, Le Gall JY, Mosser J, Gilfillan S, Bahram S.
Blood Cells Mol. Dis., 2002.

> 2001

Identification of 96 single nucleotide polymorphisms in eight genes involved in iron metabolism: efficiency of bioinformatic extraction compared with a systematic sequencing approach.
Douabin-Gicquel V, Soriano N, Ferran H, Wojcik F, Palierne E, Tamim S, Jovelin T, McKie AT, Le Gall JY, David V, Mosser J.
Hum. Genet., 2001.

Low penetrant hemochromatosis phenotype in eight families: no evidence of modifiers in the mhc region.
Sachot S, Moirand R, Jouanolle AM, Mosser J, Fergelot P, Deugnier Y, Brissot P, le Gall JY, David V.
Blood Cells Mol. Dis., 2001.

Identification of an endogenous RNA transcribed from the antisense strand of the HFE gene.
Thénié AC, Gicquel IM, Hardy S, Ferran H, Fergelot P, Le Gall JY, Mosser J.
Hum. Mol. Genet., 2001.

> 2000

Transcriptional analysis of the 69-kb sequence centromeric to HLA-J: a dense and complex structure of five genes.
Coriton O, Lepourcelet M, Hampe A, Galibert F, Mosser J.
Mamm. Genome, 2000.

The HFE gene undergoes alternate splicing processes.
Thénié A, Orhant M, Gicquel I, Fergelot P, Le Gall JY, David V, Mosser J.
Blood Cells Mol. Dis., 2000.

> 1998

HTX4, a new human gene in the MHC class I region, undergoes alternative splicing and polyadenylation processes in testis.
Lepourcelet M, Coriton O, Hampe A, Galibert F, Mosser J.
Immunogenetics, 1998.

> 1997

A highly informative dinucleotide repeat polymorphism telomeric to HLA-F.
Andrieux N, Jouanolle AM, Gandon G, Mosser J.
Immunogenetics, 1997.

A YAC contig and an STS map spanning at least 3.9 megabasepairs telomeric to HLA-A.
Mosser J, Jouanolle A, Gandon G, Andrieux N, Hampe A, David V.
Immunogenetics, 1997.

A 1200-kilobase transcription map encompassing the D6S105 locus at 6p21.3.
Mosser J, Andrieux N, Fergelot P, Gicquel I, Lelaure V, Galibert F, David V.
Immunogenetics, 1997.

> 1996

Haemochromatosis and HLA-H.
Jouanolle AM, Gandon G, Jézéquel P, Blayau M, Campion ML, Yaouanq J, Mosser J, Fergelot P, Chauvel B, Bouric P, Carn G, Andrieux N, Gicquel I, Le Gall JY, David V.
Nat. Genet., 1996.

Systematic sequencing of the human HLA-A/HLA-F region: Establishment of a cosmid contig and identification of a new gene cluster within 37 kb of sequence.
Lepourcelet M1, Andrieux N, Giffon T, Pichon L, Hampe A, Galibert F, Mosser J.
Genomics, 1996.

Structural analysis of the HLA-A/HLA-F subregion: precise localization of two new multigene families closely associated with the HLA class I sequences.
Pichon L, Carn G, Bouric P, Giffon T, Chauvel B, Lepourcelet M, Mosser J, Legall JY, David V.
Genomics, 1996.

> 1995

Retroviral-mediated gene transfer corrects very-long-chain fatty acid metabolism in adrenoleukodystrophy fibroblasts.
Cartier N, Lopez J, Moullier P, Rocchiccioli F, Rolland MO, Jorge P, Mosser J, Mandel JL, Bougnères PF, Danos O, et al.
Proc. Natl. Acad. Sci. U. S. A., 1995.

> 1994

The protein coded by the X-adrenoleukodystrophy gene is a peroxisomal integral membrane protein.
Contreras M, Mosser J, Mandel JL, Aubourg P, Singh I.
FEBS Lett., 1994.

X-linked adrenoleukodystrophy gene: identification of a candidate gene by positional cloning.
Douar AM, Mosser J, Sarde CO, Lopez J, Mandel JL, Aubourg P.
Biomed. Pharmacother., 1994.

A new human gene (DXS1357E) with ubiquitous expression, located in Xq28 adjacent to the adrenoleukodystrophy gene.
Mosser J, Sarde CO, Vicaire S, Yates JR, Mandel JL.
Genomics, 1994.

The gene responsible for adrenoleukodystrophy encodes a peroxisomal membrane protein.
Mosser J, Lutz Y, Stoeckel ME, Sarde CO, Kretz C, Douar AM, Lopez J, Aubourg P, Mandel JL.
Hum. Mol. Genet., 1994.

Genomic organization of the adrenoleukodystrophy gene.
Sarde CO, Mosser J, Kioschis P, Kretz C, Vicaire S, Aubourg P, Poustka A, Mandel JL.
Genomics, 1994.

> 1993

Adrenoleukodystrophy gene: unexpected homology to a protein involved in peroxisome biogenesis.
Aubourg P, Mosser J, Douar AM, Sarde CO, Lopez J, Mandel JL.
Biochimie, 1993.

Abnormal messenger RNA expression and a missense mutation in patients with X-linked adrenoleukodystrophy.
Cartier N, Sarde CO, Douar AM, Mosser J, Mandel JL, Aubourg P.
Hum. Mol. Genet., 1993.

Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters.
Mosser J, Douar AM, Sarde CO, Kioschis P, Feil R, Moser H, Poustka AM, Mandel JL, Aubourg P.
Nature, 1993.

> 1991

Adrenoleukodystrophy: a complex chromosomal rearrangement in the Xq28 red/green-color-pigment gene region indicates two possible gene localizations.
Feil R, Aubourg P, Mosser J, Douar AM, Le Paslier D, Philippe C, Mandel JL.
Am. J. Hum. Genet., 1991.

[3H]ramiprilat binding to the angiotensin-converting enzyme in rat renal brush-border membranes: the effect of chloride.
Grima M, Mosser J, Welsch C, Barthelmebs M, Imbs JL.
Eur. J. Pharmacol., 1991.